Pro-inflammatory/Th1 gene expression shift in high glucose stimulated mesangial cells and tubular epithelial cells.

[1]  Jurong Yang,et al.  ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy. , 2013, The international journal of biochemistry & cell biology.

[2]  S. Kaneko,et al.  CCL2/CCR2 augments the production of transforming growth factor-beta1, type 1 collagen and CCL2 by human CD45-/collagen 1-positive cells under high glucose concentrations , 2013, Clinical and Experimental Nephrology.

[3]  J. O’Shea,et al.  Helper T‐cell identity and evolution of differential transcriptomes and epigenomes , 2013, Immunological reviews.

[4]  G. Ramesh,et al.  Proximal tubule-specific overexpression of netrin-1 suppresses acute kidney injury-induced interstitial fibrosis and glomerulosclerosis through suppression of IL-6/STAT3 signaling. , 2013, American journal of physiology. Renal physiology.

[5]  H. Makino,et al.  Inflammation and the pathogenesis of diabetic nephropathy. , 2013, Clinical science.

[6]  B. Kestenbaum,et al.  Kidney disease and increased mortality risk in type 2 diabetes. , 2013, Journal of the American Society of Nephrology : JASN.

[7]  A. Duschl,et al.  STAT6-dependent and -independent mechanisms in Th2 polarization , 2012, European journal of immunology.

[8]  G. Tesch,et al.  Inflammation in Diabetic Nephropathy , 2012, Mediators of inflammation.

[9]  S. Tang,et al.  The pathogenic role of the renal proximal tubular cell in diabetic nephropathy. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  P. Greengard,et al.  IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. , 2012, Cell metabolism.

[11]  L. Morel,et al.  Aberrant Macrophages Mediate Defective Kidney Repair That Triggers Nephritis in Lupus-Susceptible Mice , 2012, The Journal of Immunology.

[12]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[13]  J. Moon,et al.  Aberrant Recruitment and Activation of T Cells in Diabetic Nephropathy , 2012, American Journal of Nephrology.

[14]  S. Holdsworth,et al.  Signal transducer and activation of transcription 6 (STAT6) regulates T helper type 1 (Th1) and Th17 nephritogenic immunity in experimental crescentic glomerulonephritis , 2011, Clinical and experimental immunology.

[15]  Yuh-Feng Lin,et al.  Role of T Cells in Type 2 Diabetic Nephropathy , 2011, Experimental diabetes research.

[16]  W. Patsch,et al.  Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy , 2011, Diabetes.

[17]  D. Scott,et al.  Activation of Protein Kinase C-ζ in Pancreatic β-Cells In Vivo Improves Glucose Tolerance and Induces β-Cell Expansion via mTOR Activation , 2011, Diabetes.

[18]  D. Harris,et al.  IL-25 induces M2 macrophages and reduces renal injury in proteinuric kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[19]  M. Hall,et al.  mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. , 2011, The Journal of clinical investigation.

[20]  L. Gesualdo,et al.  IL‐17 Expression by Tubular Epithelial Cells in Renal Transplant Recipients with Acute Antibody‐Mediated Rejection , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  F. Brosius,et al.  GLUT1 enhances mTOR activity independently of TSC2 and AMPK. , 2011, American journal of physiology. Renal physiology.

[22]  D. Harris,et al.  Transfused Macrophages Ameliorate Pancreatic and Renal Injury in Murine Diabetes Mellitus , 2011, Nephron Experimental Nephrology.

[23]  H. Bagavant,et al.  Mesangial pathology in glomerular disease: targets for therapeutic intervention. , 2010, Advanced drug delivery reviews.

[24]  C. Spencer,et al.  Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. , 2010, Immunity.

[25]  A. Sanz,et al.  Suppressors of cytokine signaling abrogate diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.

[26]  W. Paul,et al.  Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells , 2010, Science.

[27]  S. Twigg,et al.  Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. , 2009, American journal of physiology. Renal physiology.

[28]  S. Kaneko,et al.  Dendritic Cells Contribute to Autoimmune Kidney Injury in MRL-Faslpr Mice , 2009, The Journal of Rheumatology.

[29]  A. Breggia,et al.  JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells. , 2008, American journal of physiology. Renal physiology.

[30]  J. Jenkins,et al.  Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. , 2008, American journal of physiology. Renal physiology.

[31]  M. Cooper,et al.  Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent Pathway , 2008, Diabetes.

[32]  S. Kaneko,et al.  Reduction in Chronic Allograft Nephropathy by Inhibition of p38 Mitogen-Activated Protein Kinase , 2006, American Journal of Nephrology.

[33]  N. Yorioka,et al.  PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation , 2006, Clinical and experimental immunology.

[34]  H. Rabb,et al.  Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. , 2003, American journal of physiology. Renal physiology.

[35]  K. Matsushima,et al.  Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  M. G. Koerkamp,et al.  Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources. , 1999, Molecular biology of the cell.

[37]  J. Krepinsky,et al.  High glucose-induced RhoA activation requires caveolae and PKCβ1-mediated ROS generation. , 2012, American journal of physiology. Renal physiology.

[38]  T. Wada,et al.  Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  K. Matsushima,et al.  p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice. , 2003, Journal of the American Society of Nephrology : JASN.